Two Indian Generic Firms Drive 4% Of Industry Sales Growth
This article was originally published in PharmAsia News
India makers of generic drugs are driving a large increase in the growth of the nation’s pharmaceutical exports, primarily by a one-each version of Pfizer and Eli Lilly drugs.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.